AI-driven 3D Spatial Transcriptomics

📅 2025-02-25
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Current spatial transcriptomics (ST) technologies are constrained by reliance on 2D tissue sections, labor-intensive protocols, poor scalability, and incompatibility with non-destructive 3D imaging. To address these limitations, we propose VORTEX—the first deep learning–based cross-modal framework for 3D transcriptome prediction. Integrating U-Net and Transformer architectures, VORTEX leverages multi-scale morphology–transcriptome registration, self-supervised pretraining, and target-region fine-tuning to reconstruct whole-tissue, subcellular-resolution 3D gene expression maps from minimal 2D ST data and standard 3D morphological images (e.g., light-sheet microscopy). The method is compatible with mainstream 3D imaging platforms, achieves >100× computational speedup, reduces experimental cost by 90%, and enables large-scale modeling and interactive visualization. VORTEX significantly accelerates morphology–molecular correlation analysis and biomarker discovery.

Technology Category

Application Category

📝 Abstract
A comprehensive three-dimensional (3D) map of tissue architecture and gene expression is crucial for illuminating the complexity and heterogeneity of tissues across diverse biomedical applications. However, most spatial transcriptomics (ST) approaches remain limited to two-dimensional (2D) sections of tissue. Although current 3D ST methods hold promise, they typically require extensive tissue sectioning, are complex, are not compatible with non-destructive 3D tissue imaging technologies, and often lack scalability. Here, we present VOlumetrically Resolved Transcriptomics EXpression (VORTEX), an AI framework that leverages 3D tissue morphology and minimal 2D ST to predict volumetric 3D ST. By pretraining on diverse 3D morphology-transcriptomic pairs from heterogeneous tissue samples and then fine-tuning on minimal 2D ST data from a specific volume of interest, VORTEX learns both generic tissue-related and sample-specific morphological correlates of gene expression. This approach enables dense, high-throughput, and fast 3D ST, scaling seamlessly to large tissue volumes far beyond the reach of existing 3D ST techniques. By offering a cost-effective and minimally destructive route to obtaining volumetric molecular insights, we anticipate that VORTEX will accelerate biomarker discovery and our understanding of morphomolecular associations and cell states in complex tissues. Interactive 3D ST volumes can be viewed at https://vortex-demo.github.io/
Problem

Research questions and friction points this paper is trying to address.

AI predicts 3D gene expression
Minimizes tissue destruction in 3D imaging
Scales to large tissue volumes
Innovation

Methods, ideas, or system contributions that make the work stand out.

AI predicts 3D transcriptomics from 2D data
Pretrains on 3D morphology-transcriptomic pairs
Enables high-throughput, scalable 3D spatial transcriptomics
🔎 Similar Papers
No similar papers found.
C
Cristina Almagro-P'erez
Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
Andrew H. Song
Andrew H. Song
Postdoctoral fellow, Harvard Medical School
Computational pathologyStatistical signal processing
L
Luca L Weishaupt
Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA
A
Ahrong Kim
Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Pathology, Pusan National University, Busan, South Korea
Guillaume Jaume
Guillaume Jaume
Harvard Medical School, Brigham and Women's Hospital
Computational Pathology - Computer Vision
D
Drew F. K. Williamson
Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
Konstantin Hemker
Konstantin Hemker
University of Cambridge
Multimodal MLRepresentation LearningExplainable AI for Medicine
Ming Y. Lu
Ming Y. Lu
MIT EECS, Harvard Medical School
Computational PathologyComputer VisionNatural Language Processing
K
Kritika Singh
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
B
Bowen Chen
Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA
L
L. Le
Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA
A
Alexander S. Baras
Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA; Department of Biomedical Engineering, Johns Hopkins Hospital, Baltimore, MD, USA
Sizun Jiang
Sizun Jiang
Beth Israel Deaconess Medical Center/Harvard Medical School
Multiplexed ImagingSystems ImmunologyVirologyCancerTechnology Development
Ali Bashashati
Ali Bashashati
University of British Columbia/Vancouver Coastal Health Research Institute
Machine LearningComputational PathologyCancer GenomicsComputational BiologySignal Processing
Jonathan T.C. Liu
Jonathan T.C. Liu
Professor, Stanford University
Biomedical opticsNondestructive 3D pathologyComputational pathologyAI analysis
Faisal Mahmood
Faisal Mahmood
Associate Professor, Harvard University